查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2052206

吡哆醇市場：市場洞察、競爭格局及市場預測（2033 年）

Pyridoxine Market Insights, Competitive Landscape, and Market Forecast - 2033
出版日期: | 出版商: Fairfield Market Research | 英文 201 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

隨著人們健康意識的不斷提高、營養補充劑趨勢的演變以及預防醫學的持續進步，吡哆醇市場正吸引著全球的廣泛關注。吡哆醇，又稱維生素B6，是一種重要的營養素，能夠支持新陳代謝、神經功能、免疫反應和心血管健康。隨著營養平衡的重要性日益凸顯，以及健康生活方式的普及，吡哆醇的應用領域也日益廣泛。

2026年全球吡哆醇市場規模為3.445億美元，預計2033年將達到4.945億美元，預測期內年複合成長率（CAGR）為5.30%。受全球製藥企業、營養補充劑生產商以及食品強化措施需求不斷成長的推動，市場前景依然樂觀。

市場洞察

隨著人們健康意識的增強，吡哆醇的需求持續成長。消費者對維生素缺乏及其健康影響的認知不斷提高，導致全球膳食補充劑的消費量激增。為了應對這一變化，生產商正致力於開發創新配方並提高產品供應。

製藥公司正擴大將吡哆醇添加到治療代謝紊亂、神經系統疾病和營養缺乏症的製劑中。同時，食品生產商也在強化食品中添加維生素，以滿足消費者日益成長的健康飲食偏好。

此外，維生素生產技術的進步正對市場產生正面影響，有助於提高生產效率、產品均一性和供應可靠性。各公司持續加大研發投入，以支持產品多元化並增強市場競爭力。

促進因素

營養缺乏症增加

人們對微量營養素缺乏症的認知不斷提高，顯著推動了市場需求。消費者積極尋求能夠增強整體健康和免疫力的營養產品，從而導致維生素補充劑的消費量增加。

營養補充品需求不斷成長

營養補充品產業的蓬勃發展仍然是主要的成長要素。消費者健康意識的提高和對預防性醫療保健日益成長的興趣，都有助於該市場的長期發展。

擴大藥物應用

吡哆醇因其在多種治療中發揮的關鍵作用，在醫藥應用領域仍然十分重要。處方量的增加和維生素產品供應量的擴大正在推動市場成長。

強化食品的廣泛應用

食品生產商不斷產品推出強化食品和飲料，以滿足消費者對更高營養價值日益成長的需求。這一趨勢為吡哆醇供應商創造了機會。

在動物營養領域不斷擴展應用

畜牧業和動物營養領域正成為重要的需求來源。補充吡哆醇有助於促進動物生長、改善健康狀況和最佳化飼料。

商業機會

在新興經濟體，隨著醫療保健服務的改善和營養意識的提高，預計將湧現出巨大的商機。可支配收入的增加和城市生活方式的普及正在加速開發中地區營養補充劑的消費。

為了滿足消費者日益成長的需求，製造商正加大對優質配方、客製化營養產品和潔淨標示解決方案的投資。擴大產能和加強全球供應鏈仍然是產業相關人員的首要任務。

數位化零售通路透過增強企業與消費者之間的連結和直接互動，持續變革經銷網路。電子商務的廣泛應用為拓展產品線和擴大市場覆蓋範圍創造了新的機會。

此外，營養保健品、個人化營養和功能性成分的創新預計將在整個預測期內為製造商帶來新的收入來源。

區域分析

由於消費者意識高、醫療保健體系先進以及膳食補充劑的廣泛使用，北美在吡哆醇市場佔據了相當大的佔有率。預防性醫療保健力度的加強也持續推動著該地區的成長。

歐洲是一個成熟的市場，擁有健全的法規結構，消費者對營養產品的偏好日益成長。對健康解決方案的需求不斷增加，持續推動區域擴張。

由於製藥業的擴張、城市人口的成長以及醫療保健支出的增加，亞太地區預計將迎來顯著成長。人們對維生素缺乏症的日益關注也進一步增強了市場前景。

拉丁美洲正逐漸成為一個有吸引力的市場，這得益於保健品消費量的增加和醫療保健服務的改善。

中東和非洲地區在持續的醫療保健投資和人們對營養健康解決方案日益成長的認知的推動下，繼續保持穩定成長。

大公司

領先企業正致力於擴大製造地、建立策略聯盟、創新產品和最佳化供應鏈，以增強自身競爭力。

  • DSM-Firmenich
  • BASF SE
  • Huazhong Pharmaceutical Co., Ltd.
  • Jiangxi Tianxin Pharmaceutical Co., Ltd.
  • Acebright Pharmaceuticals Group Co., Ltd.
  • HuiSheng Pharma
  • Xinfa Pharmaceutical Co., Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Rochem International Inc.
  • Nanjing Pharmaceutical Factory Co., Ltd.
  • Brother Enterprises Holding Co., Ltd.
  • Prinova Group LLC
  • Lonza Group AG
  • Merck KGaA
  • Evonik Industries AG
  • Zhejiang Medicine Co., Ltd. (ZMC)
  • Jubilant Life Sciences Ltd.
  • Northeast Pharmaceutical Group Co., Ltd.

分割

依產品類型

  • 藥片
  • 膠囊
  • 粉末
  • 營養強化食品
  • 液體

透過使用

  • 補充
  • 製藥
  • 食品/飲料
  • 化妝品和個人護理
  • 動物飼料

起源

  • 自然的
  • 合成

按地區

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

目錄

第1章執行摘要

第2章 市場概覽

  • 市場定義與細分
  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 價值鏈分析
  • 新冠疫情影響分析
  • 波特五力分析
  • 俄烏衝突的影響
  • PESTLE分析
  • 監管分析
  • 價格趨勢分析
    • 當前價格及未來預測（2025-2033）
    • 價格影響因素

第3章：2020-2033年全球吡哆醇市場展望

  • 全球吡哆醇市場展望，按產品類型和價值（百萬美元）分類，2020-2033年
    • 藥片
    • 膠囊
    • 粉末
    • 營養強化食品
    • 液體
  • 全球吡哆醇市場展望，按應用領域分類，價值（百萬美元），2020-2033年
    • 營養補充品
    • 製藥
    • 食品/飲料
    • 化妝品和個人保養用品
    • 動物飼料
  • 全球吡哆醇市場展望，按來源、價值（百萬美元）分類，2020-2033年
    • 自然
    • 合成
  • 全球吡哆醇市場展望（按地區分類，價值單位：百萬美元），2020-2033年
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第4章：2020-2033年北美吡哆醇市場展望

第5章：2020-2033年歐洲吡哆醇市場展望

第6章：2020-2033年亞太地區吡哆醇市場展望

第7章：2020-2033年拉丁美洲吡哆醇市場展望

第8章：2020-2033年中東與非洲吡哆醇市場展望

第9章 競爭情勢

  • 公司與細分市場熱圖
  • 2025年各公司市佔率分析
  • 競爭對手儀錶板
  • 公司簡介
    • DSM-Firmenich
    • BASF SE
    • Huazhong Pharmaceutical Co., Ltd.
    • Jiangxi Tianxin Pharmaceutical Co., Ltd.
    • Acebright Pharmaceuticals Group Co., Ltd.
    • HuiSheng Pharma
    • Xinfa Pharmaceutical Co., Ltd.
    • Torrent Pharmaceuticals Ltd.
    • Rochem International Inc.
    • Nanjing Pharmaceutical Factory Co., Ltd.
    • Brother Enterprises Holding Co., Ltd.
    • Prinova Group LLC
    • Lonza Group AG
    • Merck KGaA
    • Evonik Industries AG

第10章附錄

簡介目錄

The Pyridoxine Market is gaining considerable traction globally as healthcare awareness, nutritional supplementation trends, and preventive healthcare practices continue to evolve. Pyridoxine, widely recognized as Vitamin B6, serves as an essential nutrient supporting metabolism, neurological functions, immune response, and cardiovascular health. Growing emphasis on nutritional balance and wellness-oriented lifestyles is increasing the adoption of pyridoxine across various end-use sectors.

The global Pyridoxine Market is valued at US$ 344.5 Mn in 2026 and is projected to reach US$ 494.5 Mn by 2033, growing at a CAGR of 5.30% during the forecast period. The market outlook remains positive due to rising demand from pharmaceutical manufacturers, dietary supplement producers, and food fortification initiatives worldwide.

Market Insights

Pyridoxine demand continues to expand due to increasing utilization across health-focused industries. Consumer awareness regarding vitamin deficiencies and their health implications has elevated supplement consumption globally. This shift is encouraging manufacturers to introduce innovative formulations and improve product accessibility.

Pharmaceutical companies increasingly incorporate pyridoxine into formulations designed for metabolic disorders, neurological conditions, and nutritional deficiencies. Simultaneously, food producers are incorporating vitamins into fortified products to address changing consumer preferences toward healthier consumption habits.

The market also benefits from technological advancements in vitamin production, which help improve manufacturing efficiency, product consistency, and supply reliability. Companies continue investing in research activities to support product diversification and strengthen market competitiveness.

Drivers

Increasing Prevalence of Nutritional Deficiencies

Growing awareness regarding micronutrient deficiencies is significantly boosting market demand. Consumers are actively seeking nutritional products that support overall health and immunity, leading to increased consumption of vitamin supplements.

Growing Demand for Dietary Supplements

The expanding dietary supplement sector remains a primary growth contributor. Rising health consciousness among consumers, coupled with greater interest in preventive healthcare, is supporting long-term market development.

Expansion of Pharmaceutical Usage

Pyridoxine maintains strong relevance within pharmaceutical applications because of its importance in various therapeutic treatments. Growing prescription volumes and broader availability of vitamin products are supporting market growth.

Rising Adoption of Fortified Foods

Food manufacturers continue introducing fortified food and beverage products to meet increasing consumer demand for enhanced nutritional value. This trend is creating favorable opportunities for pyridoxine suppliers.

Increasing Animal Nutrition Applications

The livestock and animal nutrition sectors are emerging as important demand centers. Pyridoxine supplementation contributes to improved animal growth, health performance, and feed optimization.

Business Opportunity

Emerging economies are expected to create substantial business opportunities as healthcare access improves and nutritional awareness expands. Rising disposable incomes and urban lifestyles are accelerating supplement consumption across developing regions.

Manufacturers are increasingly investing in premium-grade formulations, customized nutritional products, and clean-label solutions to capture growing consumer interest. Expanding production capacities and strengthening global supply chains remain key priorities for industry participants.

Digital retail channels continue transforming distribution networks by improving accessibility and allowing companies to directly engage with consumers. Growing e-commerce penetration presents new opportunities for product expansion and market reach.

Additionally, innovation across nutraceuticals, personalized nutrition, and functional ingredients is expected to unlock new revenue streams for manufacturers throughout the forecast period.

Region Analysis

North America maintains a significant share of the Pyridoxine Market due to strong consumer awareness, advanced healthcare systems, and widespread supplement usage. Increasing preventive healthcare initiatives continue supporting regional growth.

Europe represents an established market characterized by strong regulatory frameworks and rising consumer preference for nutritional products. Growing demand for wellness-focused solutions continues driving regional expansion.

Asia Pacific is expected to witness substantial growth owing to expanding pharmaceutical manufacturing, increasing urban populations, and rising healthcare spending. Growing awareness regarding vitamin deficiencies further strengthens market prospects.

Latin America is gradually emerging as an attractive market supported by rising supplement consumption and improving healthcare accessibility.

Middle East & Africa continues to experience steady growth due to ongoing healthcare investments and increasing awareness regarding nutrition-based wellness solutions.

Key Players

Leading companies are focusing on manufacturing expansion, strategic collaborations, product innovation, and supply chain optimization to strengthen their competitive positioning.

  • DSM-Firmenich
  • BASF SE
  • Huazhong Pharmaceutical Co., Ltd.
  • Jiangxi Tianxin Pharmaceutical Co., Ltd.
  • Acebright Pharmaceuticals Group Co., Ltd.
  • HuiSheng Pharma
  • Xinfa Pharmaceutical Co., Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Rochem International Inc.
  • Nanjing Pharmaceutical Factory Co., Ltd.
  • Brother Enterprises Holding Co., Ltd.
  • Prinova Group LLC
  • Lonza Group AG
  • Merck KGaA
  • Evonik Industries AG
  • Zhejiang Medicine Co., Ltd. (ZMC)
  • Jubilant Life Sciences Ltd.
  • Northeast Pharmaceutical Group Co., Ltd.

Segmentation

By Product Type

  • Tablets
  • Capsules
  • Powders
  • Fortified Foods
  • Liquids

By Application

  • Dietary Supplements
  • Pharmaceuticals
  • Food & Beverage
  • Cosmetics & Personal Care
  • Animal Feed

By Source

  • Natural
  • Synthetic

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Pyridoxine Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Pyridoxine Market Outlook, 2020 - 2033

  • 3.1. Global Pyridoxine Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 3.1.1. Tablets
    • 3.1.2. Capsules
    • 3.1.3. Powders
    • 3.1.4. Fortified Foods
    • 3.1.5. Liquids
  • 3.2. Global Pyridoxine Market Outlook, by Application, Value (US$ Mn), 2020-2033
    • 3.2.1. Dietary Supplements
    • 3.2.2. Pharmaceuticals
    • 3.2.3. Food & Beverage
    • 3.2.4. Cosmetics & Personal Care
    • 3.2.5. Animal Feed
  • 3.3. Global Pyridoxine Market Outlook, by Source, Value (US$ Mn), 2020-2033
    • 3.3.1. Natural
    • 3.3.2. Synthetic
  • 3.4. Global Pyridoxine Market Outlook, by Region, Value (US$ Mn), 2020-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa

4. North America Pyridoxine Market Outlook, 2020 - 2033

  • 4.1. North America Pyridoxine Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 4.1.1. Tablets
    • 4.1.2. Capsules
    • 4.1.3. Powders
    • 4.1.4. Fortified Foods
    • 4.1.5. Liquids
  • 4.2. North America Pyridoxine Market Outlook, by Application, Value (US$ Mn), 2020-2033
    • 4.2.1. Dietary Supplements
    • 4.2.2. Pharmaceuticals
    • 4.2.3. Food & Beverage
    • 4.2.4. Cosmetics & Personal Care
    • 4.2.5. Animal Feed
  • 4.3. North America Pyridoxine Market Outlook, by Source, Value (US$ Mn), 2020-2033
    • 4.3.1. Natural
    • 4.3.2. Synthetic
  • 4.4. North America Pyridoxine Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 4.4.1. U.S. Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 4.4.2. U.S. Pyridoxine Market Outlook, by Application, 2020-2033
    • 4.4.3. U.S. Pyridoxine Market Outlook, by Source, 2020-2033
    • 4.4.4. Canada Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 4.4.5. Canada Pyridoxine Market Outlook, by Application, 2020-2033
    • 4.4.6. Canada Pyridoxine Market Outlook, by Source, 2020-2033
  • 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Pyridoxine Market Outlook, 2020 - 2033

  • 5.1. Europe Pyridoxine Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 5.1.1. Tablets
    • 5.1.2. Capsules
    • 5.1.3. Powders
    • 5.1.4. Fortified Foods
    • 5.1.5. Liquids
  • 5.2. Europe Pyridoxine Market Outlook, by Application, Value (US$ Mn), 2020-2033
    • 5.2.1. Dietary Supplements
    • 5.2.2. Pharmaceuticals
    • 5.2.3. Food & Beverage
    • 5.2.4. Cosmetics & Personal Care
    • 5.2.5. Animal Feed
  • 5.3. Europe Pyridoxine Market Outlook, by Source, Value (US$ Mn), 2020-2033
    • 5.3.1. Natural
    • 5.3.2. Synthetic
  • 5.4. Europe Pyridoxine Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 5.4.1. Germany Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 5.4.2. Germany Pyridoxine Market Outlook, by Application, 2020-2033
    • 5.4.3. Germany Pyridoxine Market Outlook, by Source, 2020-2033
    • 5.4.4. Italy Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 5.4.5. Italy Pyridoxine Market Outlook, by Application, 2020-2033
    • 5.4.6. Italy Pyridoxine Market Outlook, by Source, 2020-2033
    • 5.4.7. France Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 5.4.8. France Pyridoxine Market Outlook, by Application, 2020-2033
    • 5.4.9. France Pyridoxine Market Outlook, by Source, 2020-2033
    • 5.4.10. U.K. Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 5.4.11. U.K. Pyridoxine Market Outlook, by Application, 2020-2033
    • 5.4.12. U.K. Pyridoxine Market Outlook, by Source, 2020-2033
    • 5.4.13. Spain Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 5.4.14. Spain Pyridoxine Market Outlook, by Application, 2020-2033
    • 5.4.15. Spain Pyridoxine Market Outlook, by Source, 2020-2033
    • 5.4.16. Russia Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 5.4.17. Russia Pyridoxine Market Outlook, by Application, 2020-2033
    • 5.4.18. Russia Pyridoxine Market Outlook, by Source, 2020-2033
    • 5.4.19. Rest of Europe Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 5.4.20. Rest of Europe Pyridoxine Market Outlook, by Application, 2020-2033
    • 5.4.21. Rest of Europe Pyridoxine Market Outlook, by Source, 2020-2033
  • 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Pyridoxine Market Outlook, 2020 - 2033

  • 6.1. Asia Pacific Pyridoxine Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 6.1.1. Tablets
    • 6.1.2. Capsules
    • 6.1.3. Powders
    • 6.1.4. Fortified Foods
    • 6.1.5. Liquids
  • 6.2. Asia Pacific Pyridoxine Market Outlook, by Application, Value (US$ Mn), 2020-2033
    • 6.2.1. Dietary Supplements
    • 6.2.2. Pharmaceuticals
    • 6.2.3. Food & Beverage
    • 6.2.4. Cosmetics & Personal Care
    • 6.2.5. Animal Feed
  • 6.3. Asia Pacific Pyridoxine Market Outlook, by Source, Value (US$ Mn), 2020-2033
    • 6.3.1. Natural
    • 6.3.2. Synthetic
  • 6.4. Asia Pacific Pyridoxine Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 6.4.1. China Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 6.4.2. China Pyridoxine Market Outlook, by Application, 2020-2033
    • 6.4.3. China Pyridoxine Market Outlook, by Source, 2020-2033
    • 6.4.4. Japan Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 6.4.5. Japan Pyridoxine Market Outlook, by Application, 2020-2033
    • 6.4.6. Japan Pyridoxine Market Outlook, by Source, 2020-2033
    • 6.4.7. South Korea Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 6.4.8. South Korea Pyridoxine Market Outlook, by Application, 2020-2033
    • 6.4.9. South Korea Pyridoxine Market Outlook, by Source, 2020-2033
    • 6.4.10. India Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 6.4.11. India Pyridoxine Market Outlook, by Application, 2020-2033
    • 6.4.12. India Pyridoxine Market Outlook, by Source, 2020-2033
    • 6.4.13. Southeast Asia Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 6.4.14. Southeast Asia Pyridoxine Market Outlook, by Application, 2020-2033
    • 6.4.15. Southeast Asia Pyridoxine Market Outlook, by Source, 2020-2033
    • 6.4.16. Rest of SAO Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 6.4.17. Rest of SAO Pyridoxine Market Outlook, by Application, 2020-2033
    • 6.4.18. Rest of SAO Pyridoxine Market Outlook, by Source, 2020-2033
  • 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Pyridoxine Market Outlook, 2020 - 2033

  • 7.1. Latin America Pyridoxine Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 7.1.1. Tablets
    • 7.1.2. Capsules
    • 7.1.3. Powders
    • 7.1.4. Fortified Foods
    • 7.1.5. Liquids
  • 7.2. Latin America Pyridoxine Market Outlook, by Application, Value (US$ Mn), 2020-2033
    • 7.2.1. Dietary Supplements
    • 7.2.2. Pharmaceuticals
    • 7.2.3. Food & Beverage
    • 7.2.4. Cosmetics & Personal Care
    • 7.2.5. Animal Feed
  • 7.3. Latin America Pyridoxine Market Outlook, by Source, Value (US$ Mn), 2020-2033
    • 7.3.1. Natural
    • 7.3.2. Synthetic
  • 7.4. Latin America Pyridoxine Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 7.4.1. Brazil Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 7.4.2. Brazil Pyridoxine Market Outlook, by Application, 2020-2033
    • 7.4.3. Brazil Pyridoxine Market Outlook, by Source, 2020-2033
    • 7.4.4. Mexico Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 7.4.5. Mexico Pyridoxine Market Outlook, by Application, 2020-2033
    • 7.4.6. Mexico Pyridoxine Market Outlook, by Source, 2020-2033
    • 7.4.7. Argentina Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 7.4.8. Argentina Pyridoxine Market Outlook, by Application, 2020-2033
    • 7.4.9. Argentina Pyridoxine Market Outlook, by Source, 2020-2033
    • 7.4.10. Rest of LATAM Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 7.4.11. Rest of LATAM Pyridoxine Market Outlook, by Application, 2020-2033
    • 7.4.12. Rest of LATAM Pyridoxine Market Outlook, by Source, 2020-2033
  • 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Pyridoxine Market Outlook, 2020 - 2033

  • 8.1. Middle East & Africa Pyridoxine Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 8.1.1. Tablets
    • 8.1.2. Capsules
    • 8.1.3. Powders
    • 8.1.4. Fortified Foods
    • 8.1.5. Liquids
  • 8.2. Middle East & Africa Pyridoxine Market Outlook, by Application, Value (US$ Mn), 2020-2033
    • 8.2.1. Dietary Supplements
    • 8.2.2. Pharmaceuticals
    • 8.2.3. Food & Beverage
    • 8.2.4. Cosmetics & Personal Care
    • 8.2.5. Animal Feed
  • 8.3. Middle East & Africa Pyridoxine Market Outlook, by Source, Value (US$ Mn), 2020-2033
    • 8.3.1. Natural
    • 8.3.2. Synthetic
  • 8.4. Middle East & Africa Pyridoxine Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 8.4.1. GCC Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 8.4.2. GCC Pyridoxine Market Outlook, by Application, 2020-2033
    • 8.4.3. GCC Pyridoxine Market Outlook, by Source, 2020-2033
    • 8.4.4. South Africa Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 8.4.5. South Africa Pyridoxine Market Outlook, by Application, 2020-2033
    • 8.4.6. South Africa Pyridoxine Market Outlook, by Source, 2020-2033
    • 8.4.7. Egypt Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 8.4.8. Egypt Pyridoxine Market Outlook, by Application, 2020-2033
    • 8.4.9. Egypt Pyridoxine Market Outlook, by Source, 2020-2033
    • 8.4.10. Nigeria Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 8.4.11. Nigeria Pyridoxine Market Outlook, by Application, 2020-2033
    • 8.4.12. Nigeria Pyridoxine Market Outlook, by Source, 2020-2033
    • 8.4.13. Rest of Middle East Pyridoxine Market Outlook, by Product Type, 2020-2033
    • 8.4.14. Rest of Middle East Pyridoxine Market Outlook, by Application, 2020-2033
    • 8.4.15. Rest of Middle East Pyridoxine Market Outlook, by Source, 2020-2033
  • 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. DSM-Firmenich
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. BASF SE
    • 9.4.3. Huazhong Pharmaceutical Co., Ltd.
    • 9.4.4. Jiangxi Tianxin Pharmaceutical Co., Ltd.
    • 9.4.5. Acebright Pharmaceuticals Group Co., Ltd.
    • 9.4.6. HuiSheng Pharma
    • 9.4.7. Xinfa Pharmaceutical Co., Ltd.
    • 9.4.8. Torrent Pharmaceuticals Ltd.
    • 9.4.9. Rochem International Inc.
    • 9.4.10. Nanjing Pharmaceutical Factory Co., Ltd.
    • 9.4.11. Brother Enterprises Holding Co., Ltd.
    • 9.4.12. Prinova Group LLC
    • 9.4.13. Lonza Group AG
    • 9.4.14. Merck KGaA
    • 9.4.15. Evonik Industries AG

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations